Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
202 | 3 | DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES | 52563 |
628 | 2 | SGLT2 INHIBITOR//METFORMIN//DPP 4 INHIBITOR | 14172 |
22721 | 1 | GLICLAZIDE//ARTIFICIAL CELL MICROENCAPSULATION//BIOTECHNOL DRUG DEV | 393 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | GLICLAZIDE | authKW | 1275715 | 18% | 23% | 70 |
2 | ARTIFICIAL CELL MICROENCAPSULATION | authKW | 962336 | 3% | 100% | 12 |
3 | BIOTECHNOL DRUG DEV | address | 721728 | 5% | 43% | 21 |
4 | PHARMBIOSCI PRECINCT | address | 320779 | 1% | 100% | 4 |
5 | BIOTECHNOL DRUG DEV BIOSCI PRECINCT | address | 240584 | 1% | 100% | 3 |
6 | BIOSCI PRECINCT | address | 196828 | 2% | 27% | 9 |
7 | BEZAFIBRATE INFARCT PREVENT COORDINATING | address | 180436 | 1% | 75% | 3 |
8 | SULFONYLUREA | authKW | 163565 | 12% | 4% | 48 |
9 | CHAIM SHEBA MED NEUFELD CARDIAC | address | 160389 | 1% | 100% | 2 |
10 | PHARMCURTIN HLTH INNOVAT | address | 160389 | 1% | 100% | 2 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 5422 | 45% | 0% | 177 |
2 | Pharmacology & Pharmacy | 470 | 22% | 0% | 86 |
3 | Cardiac & Cardiovascular System | 196 | 10% | 0% | 39 |
4 | Medicine, General & Internal | 166 | 11% | 0% | 43 |
5 | Medicine, Research & Experimental | 68 | 6% | 0% | 24 |
6 | Materials Science, Biomaterials | 44 | 2% | 0% | 8 |
7 | Peripheral Vascular Diseases | 24 | 3% | 0% | 12 |
8 | Chemistry, Applied | 10 | 2% | 0% | 9 |
9 | Toxicology | 10 | 2% | 0% | 9 |
10 | Engineering, Biomedical | 9 | 2% | 0% | 7 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BIOTECHNOL DRUG DEV | 721728 | 5% | 43% | 21 |
2 | PHARMBIOSCI PRECINCT | 320779 | 1% | 100% | 4 |
3 | BIOTECHNOL DRUG DEV BIOSCI PRECINCT | 240584 | 1% | 100% | 3 |
4 | BIOSCI PRECINCT | 196828 | 2% | 27% | 9 |
5 | BEZAFIBRATE INFARCT PREVENT COORDINATING | 180436 | 1% | 75% | 3 |
6 | CHAIM SHEBA MED NEUFELD CARDIAC | 160389 | 1% | 100% | 2 |
7 | PHARMCURTIN HLTH INNOVAT | 160389 | 1% | 100% | 2 |
8 | INTERNAL MED DIABETOL CLIN PHARMACOL | 117926 | 1% | 29% | 5 |
9 | ELMELETI EGESZSEGTUDOMANYI INTEZET | 106925 | 1% | 67% | 2 |
10 | ARTHRITIS UK EPIDEMIOL MUSCULOSKELETA | 80195 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DIABETES OBESITY & METABOLISM | 12371 | 5% | 1% | 19 |
2 | JOURNAL OF DIABETES AND ITS COMPLICATIONS | 9939 | 4% | 1% | 16 |
3 | DIABETES RESEARCH AND CLINICAL PRACTICE | 7720 | 6% | 0% | 23 |
4 | METABOLISM-CLINICAL AND EXPERIMENTAL | 6519 | 7% | 0% | 27 |
5 | DIABETES-METABOLISM RESEARCH AND REVIEWS | 6434 | 3% | 1% | 11 |
6 | DIABETOLOGIE UND STOFFWECHSEL | 4417 | 1% | 1% | 4 |
7 | ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY | 3441 | 1% | 1% | 5 |
8 | EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 2465 | 2% | 0% | 7 |
9 | PHILIPPINE JOURNAL OF INTERNAL MEDICINE | 2357 | 0% | 3% | 1 |
10 | JOURNAL OF PHARMACEUTICAL INNOVATION | 1441 | 1% | 1% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |